Differential activation of NF-κB, AP-1, and C/EBP in endotoxin-tolerant rats: Mechanisms for in vivo regulation of glomerular RANTES/CCL5 expression

Journal of Immunology

Volumn 170, Issue 12, 2003, Pages 6280-6291

  Pocock, Johanna ^a   Gómez Guerrero, Carmen ^b   Harendza, Sigrid ^a   Ayoub, Murwan ^a   Hernández Vargas, Purificación ^b   Zahner, Gunther ^a   Stahl, Rolf A K ^a   Thaiss, Friedrich ^a,c  

^a UNIVERSITY OF HAMBURG   (Germany)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN; CHEMOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; OLIGONUCLEOTIDE; RANTES; TRANSCRIPTION FACTOR AP 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING SITE; GLOMERULUS; MALE; MOLECULAR CLONING; NEPHRITIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN INTERACTION; RAT;

EID: 0037942781     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.170.12.6280     Document Type: Article

References (58)

1. Rossi, D., and A. Zlotnik. 2000. The biology of chemokines and their receptors. Annu. Rev. Immunol. 18:217.
2. Segerer, S., P. J. Nelson, and D. Schlöndorff. 2000. Chemokines, chemokine receptors, and renal disease: from basic science to pathophysiologic and therapeutic studies. J. Am. Soc. Nephrol. 11:152.
3. Anders, H. J., V. Vielhauer, and D. Schlöndorff. 2003. Chemokines and chemokines receptors are involved in the resolution or progression of renal disease. Kidney Int. 63:401.
4. Wolf, G., S. Aberle, F. Thaiss, P. J. Nelson, A. M. Krensky, E. G. Neilson, and R. A. K. Stahl. 1997. TNFa induces expression of the chemoattractant cytokine RANTES in cultured mouse mesangial cells. Kidney Int. 44:795.
5. Haberstroh, U., K. Stilo, J. Pocock, G. Wolf, U. Helmchen, U. Wenzel, G. Zahner, R. A. K. Stahl, and F. Thaiss. 1998. L-arginine suppresses lipopolysaccharide-induced expression of RANTES in glomeruli. J. Am. Soc. Nephrol. 9:203.
6. Nelson, P. J., H. T. Kim, W. C. Manning, T. J. Goralski, and A. M. Krensky. 1993. Genomic organization and transcriptional regulation of the RANTES chemokine gene. J. Immunol. 151:2601.
7. Shin, H. S., B. E. Drysdale, M. L. Shin, P. W. Noble, S. N. Fisher, and W. A. Paznekas. 1994. Definition of a lipopolysaccharide-rasponsive element in the 5′-flanking regions of MuRantes and crg-2. Mol. Cell. Biol. 14:2914.
8. Boehlk, S., S. Fessele, A. Mojaat, N. G. Miyamoto, T. Wemer, E. L. Nelson, D. Schlöndorff, and P. J. Nelson. 2000. ATF and Jun transcription factors, acting through an Ets/CRE promoter module, mediate lipopolysaccharide inducibility of the chemokine RANTES in monocytic Mono Mac 6 cells. Eur. J. Immunol. 30:1102.
9. Miyamoto, N. G., P. S. Medberry, J. Hesselgesser, S. Boehlk, P. J. Nelson, A. M. Krensky, and H. D. Perez. 2000. Interleukin-1β induction of the chemokine RANTES promoter in the human astrocytoma line CH235 requires both constitutive and inducible transcription factors. J. Neuroimmunol. 105:78.
10. Fessele, S., S. Boehlk, A. Mojaat, N. G. Miyamoto, T. Werner, E. L. Nelson, D. Schlöndorff, and P. J. Nelson. 2001. Molecular and in silico characterization of a promoter module and C/EBP element that medate LPS-induced RANTES/CCL5 expression in monocytic cells. FASEB J. 15:577.
11. Sakurai, H., Y. Hisada, M. Ueno, M. Sugiura, K. Kawashima, and T. Sugita. 1996. Activation of transcription factor NF-κB in experimental glomerulo-nephritis in rats. Biochim. Biophys. Acta 1316:132.
12. Sakurai, H., N. Shigemori, Y. Hisada, T. Ishizuka, K. Kawashima, and T. Sugita. 1997. Suppression of NF-κB and AP-1 activation by glucocorticoids in experimental glomerulonephritis in rats: molecular mechanism of anti-nephritic action. Biochim. Biophys. Acta 1362:252.
13. Wolf, G., F. N. Ziyadeh, F. Thaiss, J. Tomaszewski, R. J. Caron, U. Wenzel, G. Zahner, U. Helmchen, and R. A. K. Stahl. 1997. Anglotensin II stimulates expression of the chemokine RANTES in rat glomerular endothelial cells: role of the angiotensin type 2 receptor. J. Clin. Invest. 100:1047.
14. Gómez-Guerrero, C., N. Duque, M.T. Casado, C. Pastor, J. Blanco, F. Mampaso, F. Vivanco, and J. Egido. 2000. Administration of IgG Fc fragments prevents glomerular injury in experimental immune complex glomerulonephritis. J. Immunol. 164:2092.
15. Quandt, K., K. Frech, H. Haras, E. Wingender, and T. Werner. 1995. MatInd and MatInspector: new fast and versatile tools for the detection of consensus matches in nucleotide sequence data. Nucleic Acids Res. 23:4878.
16. Lloyd, C. M., A. W. Minto, M. E. Dorf, A. Proudfoot, T. N. Wells, D. J. Salant, and J. C. Gutierrez-Ramos. 1997. RANTES and monocyte chemoattractant protein-1 (MCP-1) play an important role in the inflammatory phase of crescentic nephritis, but only MCP-1 is involved in crescent formation and interstitial fibrosis. J. Exp. Med. 185:1371.
17. Zoja, C., R. Donadella, S. Colleoni, M. Figliuzzi, S. Bonazzola, M. Morigi, and G. Remuzzi. 1998. Protein overload stimulates RANTES production by proximal tubular cells depending on NF-κB activation. Kidney Int. 53:1608.
18. Gröne, H. J., C. Weber, K. S. Weber, E. F. Gröne, T. Rabelink, C. M. Klier, T. N. Wells, A. E. Proudfood, D. Schlöndorff, and P. J. Nelson. 1999. Met-RANTES reduces vascular and tubular damage during acute renal transplant rejection: blocking monocyte arrest and recruitment. FASEB J. 13:1371.
19. Panzer, U., A. Schneidar, J. Wilken, D. A. Thompson, S. B. H. Kent, and R. A. K. Stahl. 1999. The chemokine receptor antagonist AOP-RANTES reduces monocyte infiltration in experimental glomerulonephritis. Kidney Int. 56:2107.
20. Danoff, T. M., P. A. Lalley, Y. S. Chang, P. S. Heeger, and E. G. Neilson. 1994. Cloning, genomic: organization, and chromosomal localization of the Scya5 gene encoding the murine chemokine RANTES. J. Immunol. 152:1182.
21. Moriuchi, H., M. Moriuchi, and A. S. Fauci. 1997. Nuclear factor-κ-B potently up-regulates the promoter activity of RANTES, a chemokine that blocks HIV infection. J. Immunol. 158:3483.
22. Genin, P., M. Algarte, P. Roof, R. Lin, and J. Hiscott. 2000. Regulation of RANTES chemokine gene expression requires cooperativity between NF-κB and IFN-regulatory factor transcription factors. J. Immunol. 164:5352.
23. Saccani, S., S. Pantano, and G. Natoli. 2001. Two waves of nuclear factor κB recruitment to target promoters. J. Exp. Med. 193:1351.
24. Fessele, S., H. Maier, C. Zischek, P. J. Nelson. and T. Wemer. 2002. Regulatory context is a crucial part of gene function. Trends Genet. 18:60.
25. Poli, V. 1998. The role of C/EBP isoforms in the control of inflammatory and native immunity functions. J. Biol. Chem. 273:29279.
26. Hu, H. M., Q. Tian, M. Baer, C. J. Spooner, S. C. Williams, P. F. Johnson, and R. C. Schwartz. 2000. The C/EBP bZIP domain can mediate lipopolysaccharide induction of the proinflammatory cytokines interleukin-6 and monocyte chemoat-tractant protein-1. J. Biol. Chem. 275:16373.
27. He, Y., and E. Crouch. 2002. Surfactant protein D gene regulation: interactions among the conserved CCAAT/enhancer-binding protein elements. J. Biol. Chem. 277:19530.
28. Morrissey, J., and S. Klahr. 1998. Transcription factor NF-κB regulation of renal fibrosis during ureteral obstruction. Semin. Nephrol. 18:603.
29. Tomita, N., R. Morishita, S. Tomita, G. H. Gibbons, L. Zhang, M. Horiuchi, Y. Kaneda, J. Higaki, T. Ogihara, and V. J. Dzau. 2000. Transcription factor decoy for NF κB inhibits TNF-alpha-induced cytokine and adhesion molecule expression in vivo. Gene Ther. 7:1326.
30. Guijarro, C., and J. Egido. 2001. Transcription factor-κB (NF-κB) and renal disease. Kidney Int. 59:415.
31. Ruiz-Ortega, M., O. Lorenzo, M. Rupérez, J. Blanco, and J. Egido. 2001, Systemic infusion of angiotensin II into normal rats activates nuclear factor-κB and AP-1 in the kidney. Am. J. Pathol. 158:1743.
32. Lopez-Franco, O., Y. Suzuki, G. Sanjuan, J. Blanco, P. Hernandez-Vargas, Y. Yo, J. Kopp, J. Egido, and C. Gomez-Guerrero. 2002. Nuclear factor-κB inhibitors as potential novel anti-inflammatory agents for the treatment of immune glomemlonephritis. Am. J. Pathol. 161:1497.
33. Kohler, N. G., and A. Joly. 1997. The involvement of an LPS inducible IκB kinase in endotoxin tolerance. Biochem. Biophys. Res. Commun. 232:602.
34. Bohuslav, J., V. V. Kraychenko, G. C. Parry, J. H. Erlich, S. Gerondakis, N. Mackman, and R. J. Ulevitch. 1998. Regulation of an essential innate immune response by the p50 subunit of NF-κB. J. Clin. Invest. 102:1645.
35. Li, L., S. Cousart, J. Hu, and C. E. McCall. 2000. Characterization of intedeukin-I receptor-associated kinase in normal and endotoxin-tolerant cells. J. Biol. Chem. 275:23340.
36. Medvedev, A. E., K. M. Kopydlowski, and S. N. Vogel. 2000. Inhibition of lipopolysaccharide-induced signal transduction in endotoxin-tolerized mouse macrophages: dysregulation of cytokine, chemokine, and Toll-like receptor 2 and 4 gene expression. J. Immunol. 164:5564.
37. Medvedev, A. E., P. Henneke, A. Schromm, E. Lien, R. Ingalls, M. J. Fenton, D. T. Golenbock, and S. N. Vogel. 2001. Induction of tolerance to lipopolysaccharide and mycobacterial components in Chinese hamster ovary/CD14 cells is not affected by overexpression of Toll-like receptors 2 or 4. J. Immunol. 167:2257.
38. Kinjyo, I., T. Hanada, K. Inagaki-Ohara, H. Mori, D. Aki, M. Ohishi, H. Yoshida, M. Kubo, and A. Yoshimura. 2002. SOCS1/JAB is a negative regulator of LPS-induced macrophage activation. Immunity 17:583.
39. Nakagawa, R., T. Naka, H. Tsursui, M. Fujimoto, A. Kimura, T. Abe, E. Seki, S. Sato, O. Takeuchi, K. Takeda, et al. 2002. SOCS-1 participates in negative regulation of LPS responses. Immunity 17:677.
40. Vietor, I., I. C. Oliveira, and J. Vilcek. 1996. CCAAT box enhancer binding protein a (C/EBP-a) stimulates κB element-mediated transcription in transfected cells. J. Biol. Chem. 271:5595.
41. Ruocco, M. R., X. Chen, C. Ambrosino, E. Dragenetti, W. Liu, M. Mallardo, G. DeFalco, C. Palmieri, G. Franzoso, I. Quinto, et al. 1996. Regulation of HIV-1 long terminal repeats by interaction of C/EBP (NF-IL6) and NF-κB/Rel transcription factors. J. Biol. Chem. 271:25479.
42. 2 and tumor necrosis factor-α induced differential binding of the redox-responsive transcription factors AP-1 and NF-κB to the interleukin-8 promoter in endothelial and epithelial cells. J. Biol. Chem. 273:32670.
43. Hall, A. J., H. L. Vos, and R. M. Bertina. 1999. Lipopolysaccharide induction of tissue factor in THP-1 cells involves Jun protein phosphorylation and nuclear factor κB nuclear translocation. J. Biol. Chem. 274:376.
44. Tuyt, L. M. L., W. H. A. Dokter, K. Birkenkamp, S. B. Koopmans, C. Lummen, W. Kruijer, and E. Vellenga. 1999. Extracellular-regulated kinase I/2, Jun N-terminal kinase, and c-Jun are involved in NF-κB-dependent IL-6 expression in human monocytes. J. Immunol. 162:4893.
45. Eberhardt, W., A. Huwiler, K. F. Beck, S. Walpen, and J. Pfeilachifter. 2000. Amplification of IL-1β-induced matrix metalloproteinase-9 expression by super-oxide in rat glomerular mesangial cells is mediated by increased activities of NF-κB and activating protein-1 and involves activation of the mitogen-activated protein kinase pathways. J. Immunol. 165:5788.
46. Agrawal, A., H. Cha-Molstad, D. Samols, and I. Kushner. 2001. Transactivation of C-reactive protein by IL-6 requires synergistic interaction of CCAAT/enhancer binding protein β (C/EBPβ) and Rel p50. J. Immunol. 166:2378.
47. + T cells express pertubed AP-1 and NF-κB transcription factors. Proc. Natl. Acad Sci. USA 93:979.
48. + T cells exposed to peripheral self-antigens. J. Immunol. 166:4399.
49. Dechend, R., F. Hirano, K. Lehmann, V. Heissmeyer, S. Ansieau, F. G. Wulczyn, C. Scheidereit, and A. Leutz. 1999. The Bcl-3 oncoprotein acts as a bridging factor between NF-κB/Rel and nuclear co-regulators. Oncogene 18:3316.
50. 2-macroglobulin expression is due to activation of NF-κB. J. Immunol. 167:1469.
51. Kopydlowski, K. M., C. A. Salkowski, M. J. Cody, N. van Rooijen, J. Major, T. A. Hamilton, and S. N. Vogel. 1999. Regulation of macrophage chemokines expression by lipopolysaccharide in vitro and in vivo. J. Immunol. 163:1537.
52. Chen, F. E., D. B. Huang, Y. Q. Chen, and G. Ggosh. 1998. Crystal structure of p50/p65 heterodimer of transcription factor NF-κB bound to DNA. Nature 391:410.
53. Chen-Park, F. E., D. B. Huang, B. Noro, D. Thanos, and G. Ghosh. 2002. The κB DNA sequence from the HIV long terminal repeat functions as an allosteric regulator of HIV transcription. J. Biol. Chem. 277:24701.
54. Berkowitz, B., D. B. Huang, F. E. Chen-Park, P. B. Sigler, and G. Ghosh. 2002. The x-ray crystal structure of the NF-κB p50 · p65 heterodimer bound to the interferon β-κB site. J. Biol. Chem. 277:24694.
55. Razin, A. 1998. CpG methylation, chromatin structure and gene silencing: a three-way connection. EMBO J. 17:4905.
56. Dillon, N., and R. Festenstein. 2002. Unravelling heterochromatin: competition between positive and negative factors regulates accessibility. Trends Genet. 18:252.
57. Berger, S. L. 2002. Histone modifications in transcriptional regulation. Curr. Opin. Genet. Dev. 12:142.
58. Weinmann, A. S., D. M. Mitchell, S. Sanjabi, M. N. Bradley, A. Hoffmann, H. C. Liou, and S. T. Smale. 2001. Nucleosome remodeling at the IL12 p40 promoter is a TLR-dependent, Rel-independent event. Nat. Immunol. 2:51.